Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma
Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer
Micafungin Bests Fluconazole In Phase III Antifungal Trial
Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients
Navelbine+Herceptin: 78% Response In Breast Cancer
Substance From Sea Squirts In Phase II For Breast Cancer
Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds
More Surgical Patients Die When Nurse Caseloads Rise
Neural Stem Cells Track, Treat, Brain Tumors In Mice
Cancer Clinical Trials Approved By NCI Last Month Are Listed
Trending Stories
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Thomas B. Tomasi Jr., Roswell Park president and CEO from 1986 to 1996, dies at 97
An architect of today’s Roswell Park
